Risk factors for intussusception in infants in Vietnam and Australia: Adenovirus implicated, but not rotavirus
Objective
This study aimed to investigate risk factors for the development of intussusception in infants in a developing country with a suspected high incidence and in a developed country with a low incidence.
Study design
A prospective case-control study of infants <2 years of age with idiopathic intussusception confirmed by air enema or surgery was conducted at the National Hospital of Paediatrics (NHP), Vietnam (n = 533) and the Royal Children’s Hospital (RCH), Australia (n = 51). Diagnosis was validated in a subset (84% NHP; 67% RCH) by an independent blinded radiologist. Risk factor assessment was performed using a standardized questionnaire. Stool specimens were assayed for bacterial, viral, and parasitic agents.
Results
The incidence of intussusception in Vietnam was 302/100,000 in infants <1 year of age (95% CI: 258-352), substantially higher than in Australia (71/100,000). A strong association with adenovirus infection was observed at both sites (cases positive at NHP: 34%, OR 8.2; cases positive at RCH: 40%, OR 44). No association was identified between intussusception and rotavirus, other enteric pathogens, oral polio vaccine, feeding practices, or living conditions.
Conclusions
The incidence of intussusception in infants was markedly higher in Vietnam than in Australia. A strong association between adenovirus infection and intussusception was identified at both sites suggesting that adenovirus may play a role in the etiology of intussusception.
Abbreviations: NHP, National Hospital of Paediatrics, OPV, Oral polio vaccine, RCH, Royal Children’s Hospital
To access this article, please choose from the options below
Supported by a Research Grant from Vaccines and Biologicals, Initiative in Vaccine Research, World Health Organisation, Geneva. The funding source had no involvement in the study design, data collection, data analysis, data interpretation, or writing of the report.Members of our group have received research grants for studies on rotavirus and intussusception surveillance in Australia from GlaxoSmithKline and CSL Pty. Ltd., but these have had no influence on the initiation, design, or data analysis of this study or preparation of this manuscript.
PII: S0022-3476(06)00307-6
doi:10.1016/j.jpeds.2006.04.010
© 2006 Mosby, Inc. All rights reserved.
Refers to article:
- Nosocomial rotavirus infections: A systematic review
- New rotavirus vaccines: Renewed optimism
